Cargando…

Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung

PURPOSE: The main objective of this study was to evaluate the association between polymorphisms of the target genes of pemetrexed and clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with pemetrexed. MATERIALS AND METHODS: We assessed polymorphisms at 8 sites in 4 genes [thym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Minkyu, Lee, Chul Ho, Park, Hyung Soon, Lee, Ji Hyun, Kang, Young Ae, Kim, Se Kyu, Chang, Joon, Kim, Dae Joon, Rha, Sun Young, Kim, Joo Hang, Cho, Byoung Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663241/ https://www.ncbi.nlm.nih.gov/pubmed/23709418 http://dx.doi.org/10.3349/ymj.2013.54.4.854

Ejemplares similares

EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
por: Jung, Minkyu, et al.
Publicado: (2012)

Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib
por: Jung, Minkyu, et al.
Publicado: (2012)

Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
por: Jung, Minkyu, et al.
Publicado: (2013)

Predictive factors for long‐term responders of pemetrexed maintenance treatment in non‐small cell lung cancer
por: Yoon, Joon‐Young, et al.
Publicado: (2019)

Elevated Serum C-Reactive Protein as a Prognostic Marker in Small Cell Lung Cancer
por: Hong, Soojung, et al.
Publicado: (2012)

Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial
por: Park, Cheol-Kyu, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor Type 1 (PAI-1) A15T Gene Polymorphism Is Associated with Prognosis in Patients with EGFR Mutation Positive Pulmonary Adenocarcinoma
por: Lim, Ju Eun, et al.
Publicado: (2013)

Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers
por: Ahn, Jin Woo, et al.
Publicado: (2014)

Interstitial Pneumonitis after Treatment with Pemetrexed for Non-small Cell Lung Cancer
por: Kim, Kyeong-Hyun, et al.
Publicado: (2013)

The prognostic factors of resected non-small cell lung cancer with chest wall invasion
por: Lee, Chang Young, et al.
Publicado: (2012)

Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer
por: Jo, Jaemin, et al.
Publicado: (2018)

Peroral Endoscopic Myotomy for Treating Achalasia in an Animal Model: A Feasibility Study
por: Bang, Byoung Wook, et al.
Publicado: (2013)

A Case of Locally Advanced Well-Differentiated Fetal Adenocarcinoma of the Lung Treated with Concurrent Chemoradiation Therapy
por: Kyung, Chanhee, et al.
Publicado: (2013)

Effects of Sophorae Radix on Human Gastric and Colorectal Adenocarcinoma Cells: Sophorae Radix and Cancer Cells
por: Kim, Min-Chul, et al.
Publicado: (2012)

Comprehensive pharmacogenomic characterization of gastric cancer
por: Sa, Jason K., et al.
Publicado: (2020)

Predictive factors for a long-term response duration in non-squamous cell lung cancer patients treated with pemetrexed
por: Park, Sojung, et al.
Publicado: (2016)

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers
por: Sa, Jason K., et al.
Publicado: (2019)

Pharmacogenomic analysis indicates potential of 1,5-isoquinolinediol as a universal anti-aging agent for different tissues
por: Park, Mi Sung, et al.
Publicado: (2015)

Pemetrexed in Previously Treated Non-small Cell Lung Cancer Patients with Poor Performance Status
por: Sun, Young JUNG, et al.
Publicado: (2011)

The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
por: Kim, Hye Ryun, et al.
Publicado: (2013)

Antibody-dependent cellular cytotoxicity-null effector developed using mammalian and plant GlycoDelete platform
por: Kang, Cho Eun, et al.
Publicado: (2022)

Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection
por: Lee, Eun Hye, et al.
Publicado: (2017)

Retroperitoneal single-site robot-assisted partial nephrectomy using Lapsingle Vision advanced access platform: initial three case reports
por: Lee, Hyung Ho, et al.
Publicado: (2020)

Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome
por: Lee, Jin, et al.
Publicado: (2023)

Clinically beneficial continued treatment with gefitinib after asymptomatic progression of lung adenocarcinoma
por: Choi, Hayoung, et al.
Publicado: (2015)

Recurrent Cardioembolic Stroke Treated Successfully with Repeated Mechanical Thrombectomy within the Acute Index Stroke Period
por: Lee, Yoonju, et al.
Publicado: (2015)

Macrophage activation syndrome in a newborn infant born to a untreated mother with adult onset still disease
por: Rhim, Jung Woo, et al.
Publicado: (2014)

Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
por: Kim, Han Sang, et al.
Publicado: (2013)

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma
por: Lin, Zhong, et al.
Publicado: (2017)

Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial
por: Lim, Sung Won, et al.
Publicado: (2018)

Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells
por: Kim, Eun Young, et al.
Publicado: (2014)

Cannabidiol for Treating Lennox-Gastaut Syndrome and Dravet Syndrome in Korea
por: Koo, Chung Mo, et al.
Publicado: (2020)

Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
por: Hong, Junshik, et al.
Publicado: (2010)

Two Lung Masses with Different Responses to Pemetrexed
por: Park, Kwang Young, et al.
Publicado: (2010)

PG-path: Modeling and personalizing pharmacogenomics-based pathways
por: Hong, Joo Young, et al.
Publicado: (2020)

Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial
por: Kim, J.H., et al.
Publicado: (2021)

Elevated Expression of Cathepsin K in Periodontal Ligament Fibroblast by Inflammatory Cytokines Accelerates Osteoclastogenesis via Paracrine Mechanism in Periodontal Disease
por: Heo, Soon Chul, et al.
Publicado: (2021)

Gastrin-Releasing Peptide (GRP) Stimulates Osteoclastogenesis in Periodontitis
por: Choi, YunJeong, et al.
Publicado: (2020)

Profiling Age-Related Epigenetic Markers of Stomach Adenocarcinoma in Young and Old Subjects
por: Kim, Byoung-Chul, et al.
Publicado: (2015)

A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin
por: Kim, Jung Sun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g64d6l8lu1a7den3ljn8oikg9i